La description :nanobiotix: nanomedicine for cancer treatment...
Classement Alexa Global: # 1,600,552
Server:nginx... X-Powered-By:PleskLin
L'adresse IP principale: 185.133.55.26,Votre serveur -,-
ISP:- TLD:com Code postal:-
Ce rapport est mis à jour en 20-Jul-2018
Created Date:
2001-07-26
Changed Date:
2017-06-08
Données techniques du nanobiotix.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte nanobiotix.com.Actuellement, hébergé dans - et son fournisseur de services est - .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé nginx contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 10, mail exchanger = nanobiotix-com.mail.protection.outlook.com.
HtmlToText
changed caused website to not open-- scientists healthcare professionals patients investors medias about us join the team contact meet us share search en/fr scientists healthcare professionals patients investors medias about us join the team contact meet us en/fr share share share share share type here & click enter nanomedicine for better and longer life june 21, 2018 nanobiotix announces positive phase ii/iii topline data in soft tissue sarcoma with nbtxr3 read more nanoxray a first-in-class radioenhancer a first-in-class radioenhancer discover «we work to provide innovative treatments to help patients to live longer and better.» colette, clinical team «i work for life.» céline, discovery team «we fight for meaningful goals together.» aly, finance team «nanomedicine is more than evolution, it’s a revolution!» regis, manufacturing and supply team «enthusiasm, faith in nanomedicine and love for innovation!» julie, discovery team scientists healthcare professionals patients investors media nanomedicine for better and longer life june 21, 2018: positive phase ii/iii topline data in soft tissue sarcoma with nbtxr3 news our product: nbtxr3 meet us at: bio convention , boston stock information about us join the team! publications scientists healthcare professionals clinical research patients investors corporate presentation modal video here financial | nanobiotix revenue for the 2nd quarter of 2018 july 12, 2018 scientific clinical | nanobiotix announces positive phase ii/iii topline data in soft tissue sarcoma with nbtxr3 june 21, 2018 financial | nanobiotix’ management statement on recent share price variation june 6, 2018 nanobiotix 2018 terms of use · imprint
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: NANOBIOTIX.COM
Registry Domain ID: 75400797_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2017-06-08T14:02:07Z
Creation Date: 2001-07-26T20:14:07Z
Registry Expiry Date: 2025-07-26T20:14:07Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.NETSAMPLE.COM
Name Server: NS2.NETSAMPLE.COM
Name Server: NS3.NETSAMPLE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-13T22:06:07Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Gandi SAS
SERVERS
SERVER com.whois-servers.net
ARGS domain =nanobiotix.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME nanobiotix.com
CHANGED 2017-06-08
CREATED 2001-07-26
STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus